Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.38B.
ENTERPRISE VALUE (EV)
$1.38B
GoodRx Holdings, Inc.
Market Cap
$1.16B
Enterprise Value (EV)
$1.38B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| GoodRx Holdings, Inc. (GDRX) | $1.16B | $1.38B |
| Nektar Therapeutics (NKTR)vs › | $1.17B | $1.27B |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | $884.29M |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.13B | $590.83M |
| Kardigan, Inc. (KARD)vs › | $1.12B | $753.23M |
| Harrow Health, Inc. (HROW)vs › | $1.12B | $1.34B |
| MannKind Corporation (MNKD)vs › | $1.19B | $1.47B |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | $1.57B |
| Innovage Holding Corp. (INNV)vs › | $1.21B | $1.20B |
| Cronos Group Inc. (CRON)vs › | $1.21B | $746.81M |
Market Cap
$1.16B
Total Debt
$488.26M
Cash
$261.82M
Enterprise Value
$1.38B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
